Joan Massague

This inventor holds 21 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Treatment. Top assignees: Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research, Hsc Research and Development Limited Partnership. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan Massague. Retrieved from https://idiyas.com/inventor/joan-massague

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 7)

% Patents Active = 76.2

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 215(Granted Patents)

Company Filing History:

8 out of 621

Memorial Sloan Kettering Cancer Center

patents

6 out of 519

Sloan-Kettering Institute for Cancer Research

patents

2 out of 36

Hsc Research and Development Limited Partnership

patents

4. 1 out of 309

Fred Hutchinson Cancer Center

patents

5. 1 out of 1

Telios Pharmaceuticals, Inc.

patent

6. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Metastatic Cancer

Brain Metastasis

Blood Barrier Permeability

Migrastatins

P27 Protein

Anti-Metastatic Agents

Nucleic Acid Molecules

TGF-Binding Endoglin

Breast Cancer

Assay Methods

Protein Detection

Regulatory Activity

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678501 - Modulating permeability of the blood cerebrospinal fluid barrier (2026-07-14),

2. 12059480 - Treating metastatic cancer and model systems for metastatic disease (2024-08-13),

3. 12029717 - Methods for treating brain metastasis (2024-07-09),

4. 11464874 - Treating metastatic cancer and model systems for metastatic disease (2022-10-11),

5. 11305014 - Modulating permeability of the blood cerebrospinal fluid barrier (2022-04-19),

6. 11058665 - Methods for treating brain metastasis (2021-07-13),

7. 10413522 - Methods for treating brain metastasis (2019-09-17),

8. 9546146 - Migrastatins and uses thereof (2017-01-17),

9. 9303009 - Migrastatins and uses thereof (2016-04-05),

10. 8906606 - Method of predicting and reducing risk of metastasis of breast cancer to lung (2014-12-09),

11. 8178505 - Method of predicting and reducing risk of metastasis of breast cancer to lung (2012-05-15),

12. 7829066 - Assay for anti-metastatic agents (2010-11-09),

13. 6635450 - Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents (2003-10-21),

14. 6355774 - Isolated p27 protein (2002-03-12),

15. 6316208 - Methods for determining isolated p27 protein levels and uses thereof (2001-11-13),

Title: The Innovative Mind of Joan Massague

Introduction: Joan Massague is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to the field of biomedicine and cancer research.

Latest Patents: Joan Massague holds several patents related to novel cancer treatment methods and innovative drug delivery systems, with a focus on targeting specific cancer cells while minimizing side effects.

Career Highlights: With a distinguished career spanning over three decades, Joan Massague has served as a leading researcher at prestigious institutions such as Memorial Sloan Kettering Cancer Center in New York. Her work has significantly advanced our understanding of cancer metastasis and tumor microenvironments.

Collaborations: Throughout her career, Joan Massague has collaborated with top scientists, medical professionals, and pharmaceutical companies to translate her research findings into practical applications. Her collaborative efforts have led to the development of cutting-edge therapies for various types of cancer.

Conclusion: Joan Massague's relentless pursuit of innovation and her commitment to improving cancer treatment have solidified her reputation as a trailblazing inventor in the field of biomedicine. Her work continues to inspire future generations of researchers and inventors in the fight against cancer.

Profile summary based on public USPTO records.